Condition
Cricopharyngeal Achalasia
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by Botulinum Toxin Type A
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Unknown3
Clinical Trials (3)
Showing 3 of 3 trials
NCT06213662Not ApplicableUnknownPrimary
Effect of Botulinum Toxin Injection Guided by Ultrasound Combined With Balloon Localization on Cricopharyngeal Achalasia
NCT06328556Not ApplicableUnknownPrimary
Ultrasound-guided Botulinum Toxin Injection on Cricopharyngeal Muscle Dysfunction
NCT06271395Not ApplicableUnknownPrimary
Ultrasound-guided Botulinum Toxin Injection on Cricopharyngeal Muscle Dysfunction
Showing all 3 trials
Research Network
Common Treatments
- Botulinum Toxin Type A1
- Injection1
- Injectable Type A Botulinum Toxin1
Active Sponsors
- The First Affiliated Hospital of Zhengzhou University1
- Copka Sonpashan1
- Zeng Changhao1
Top Investigators
Site Coordinator of United Medical Group
Site Coordinator of United Medical Group
The First Affiliated Hospital of Zhengzhou University
Related Conditions
- Dysphagia1